Home > Insider Trading > Filing (0001104659-23-001570)

Filing Details

Accession Number:: 0001104659-23-001570
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-01-05 19:01:19
Reporting Period:: 2023-01-03

Accepted Time:: 2023-01-05 19:01:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1609550	Inspire Medical Systems Inc.	INSP	Surgical & Medical Instruments & Apparatus (3841)	261377674

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1737127	Randy Ban	C/O Inspire Medical Systems, Inc. 5500 Wayzata Blvd., Suite 1600 Golden Valley MN 55416	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-01-03	10,000	$0.94	10,304	No	4	M	Direct
Common Stock	Disposition	2023-01-03	2,400	$250.62	7,904	No	4	S	Direct
Common Stock	Disposition	2023-01-03	2,600	$251.64	5,304	No	4	S	Direct
Common Stock	Disposition	2023-01-03	3,788	$252.71	1,516	No	4	S	Direct
Common Stock	Disposition	2023-01-03	1,056	$253.79	460	No	4	S	Direct
Common Stock	Disposition	2023-01-03	156	$255.98	304	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2023-01-03	10,000	$0.00	10,000	$0.94

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
21,090		2027-04-01	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	167	Indirect	By son
Common Stock	166	Indirect	By daughter

Footnotes

Includes 19 additional shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on December 6, 2022.
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.09 to $251.05, inclusive.
The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.22 to $252.15, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.26 to $253.16, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.41 to $254.2966, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.97 to $256.00, inclusive.
The option is fully vested and exercisable.